Fri, 12 August 2022
VC Fund Core Documents Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing. In raising a fund, you’ll need to set up the legal documents that define how and when the limited partners provide the funds, what the fund manager will do with those funds, and how they will return the funds back to the limited partners. Here are some key details to include in a fund document:
For more episodes from Investor Connect, please visit the site at: http://investorconnect.org Check out our other podcasts here: https://investorconnect.org/ For Feedback please contact info@tencapital.group Please follow, share, and leave a review. Music courtesy of Bensound. |
Fri, 12 August 2022
On this episode of Investor Connect, Hall welcomes Dr. Ipshita Mandal-Johnson, Co-founder and CEO, and Giorgio Reggiani, Co-founder and CFO at Global Bio Fund. GBF is a value-capital fund with a gender smart lens investing in bio sectors, including digital health. They invest and scale women-led bio ventures at early and growth stages, especially those based in the US, UK, Australasia, and selected high-growth emerging markets. GBF has also created GBX, a network that consists of a diverse and experienced group of investors, entrepreneurs, scientists, experts, and organizations that support women-led bio ventures that are growth and impact-oriented. Ipshita currently serves on the advisory boards of Proximie, Chiasma NZ, and Global Engineering Futures. She is a Judge on Mass Challenge and Women in Bio and a member of Global Women and UNAIDS HIEx Investors Council. She is a Visiting Lecturer at the Harvard School of Public Health and the University of Cambridge Chemical Engineering & Biotech. Ipshita has worked with academia, corporates, and ministries in biotechnology, health, deep technology, and financial services. She has led strategy, policy, and implementation projects in policy development, capacity building, business development, fundraising, and transformation. She started her career in New Zealand and has since worked in the US, UK, and India, amongst others. For her full bio, click here. Giorgio is passionate about working with teams that want to make a difference by helping them to create and realise optimum value. Co-founder of a leading European venture capitalist firm, a software configuration company, an antibiotics discovery company (sold to Summit in 2017), and a rare diseases therapies biotech (sold to Astellas Pharma) in 2020 and spun companies out of British Telecom & Toshiba and managed listed companies in London and Sydney. For his full bio, click here. Visit Global Bio Fund at www.globalbiofund.org, on LinkedIn at www.linkedin.com/company/global-bio-fund/, and on Twitter at www.twitter.com/GlobalBioFund. Reach out to Giorgio at giorgio.reggiani@globalbiofund.org, and on LinkedIn at www.linkedin.com/in/giorgioreggiani/. _______________________________________________________ For more episodes from Investor Connect, please visit the site at: http://investorconnect.org Check out our other podcasts here: https://investorconnect.org/ For Feedback please contact info@tencapital.group Please follow, share, and leave a review. Music courtesy of Bensound.
Direct download: Ipshita_Mandal_Johnson_and_Giorgio_Reggiani_of_Global_Bio_Fund_2.mp3
Category:general -- posted at: 6:00am CDT |